We are live on ! Find out more
Qube Research & Technologies (QRT)

Qube Research & Technologies (QRT) Portfolio holdings

AUM $89.9B
1-Year Est. Return 20.22%
This Fund
S&P 500
This Quarter Est. Return
-6.27%
1 Year Est. Return
+20.22%
3 Year Est. Return
+42.42%
5 Year Est. Return
+23.97%
10 Year Est. Return
AUM
$16.8B
AUM Growth
+$3.24B
Cap. Flow
+$4.87B
Cap. Flow %
28.99%
Top 10 Hldgs %
10.37%
Holding
3,295
New
862
Increased
762
Reduced
768
Closed
837

Top Buys

Rank Stock Value
1
V icon
Visa
V
+$169M
2
KO icon
Coca-Cola
KO
+$155M
3
MCD icon
McDonald's
MCD
+$140M
4
MDLZ icon
Mondelez International
MDLZ
+$127M
5
DRE
Duke Realty Corp.
DRE
+$120M

Sector Composition

Rank Sector Weight
1 Technology 20.63%
2 Financials 11.8%
3 Healthcare 10.7%
4 Industrials 9.22%
5 Consumer Discretionary 8.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AKBA icon
2076
Akebia Therapeutics
AKBA
$341M
$66K ﹤0.01%
209,755
-388,624
-65% -$152K
VHC icon
2077
VirnetX Holding Corp
VHC
$54.4M
$66K ﹤0.01%
2,811
-373
-12% -$12K
DMTK
2078
DELISTED
DermTech, Inc. Common Stock
DMTK
$66K ﹤0.01%
16,735
-21,777
-57% -$134K
XNTK icon
2079
State Street SPDR NYSE Technology ETF
XNTK
$2B
$65K ﹤0.01%
+695
New +$75.6K
ADVM
2080
DELISTED
Adverum Biotechnologies
ADVM
$64K ﹤0.01%
6,756
-1,633
-19% -$21.5K
DRIO icon
2081
DarioHealth
DRIO
$54.8M
$64K ﹤0.01%
691
-88
-11% -$9.45K
IYG icon
2082
iShares US Financial Services ETF
IYG
$2.18B
$64K ﹤0.01%
1,356
-522
-28% -$27.4K
STIM icon
2083
Neuronetics
STIM
$130M
$64K ﹤0.01%
19,999
-2,686
-12% -$9.76K
TERN
2084
DELISTED
Terns Pharmaceuticals
TERN
$64K ﹤0.01%
10,809
-599
-5% -$2.23K
CTLP
2085
DELISTED
Cantaloupe
CTLP
$63K ﹤0.01%
+17,976
New +$98.6K
FXU icon
2086
First Trust Utilities AlphaDEX Fund
FXU
$836M
$63K ﹤0.01%
2,053
+71
+4% +$2.41K
ILCG icon
2087
iShares Morningstar Growth ETF
ILCG
$3.06B
$63K ﹤0.01%
1,300
-917
-41% -$49.6K
PBYI icon
2088
Puma Biotechnology
PBYI
$406M
$63K ﹤0.01%
26,545
-2,765
-9% -$8.07K
REM icon
2089
iShares Mortgage Real Estate ETF
REM
$553M
$63K ﹤0.01%
+2,991
New +$84K
LENZ
2090
LENZ Therapeutics
LENZ
$184M
$63K ﹤0.01%
2,856
+336
+13% +$8.01K
OMGA
2091
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
$63K ﹤0.01%
11,618
-2,001
-15% -$10.1K
EES icon
2092
WisdomTree US SmallCap Earnings Fund
EES
$727M
$62K ﹤0.01%
1,582
+1,493
+1,678% +$65K
NWG icon
2093
NatWest
NWG
$70.6B
$62K ﹤0.01%
+12,374
New +$76.2K
XSVM icon
2094
Invesco S&P SmallCap Value with Momentum ETF
XSVM
$684M
$62K ﹤0.01%
1,505
-3,700
-71% -$172K
CARM
2095
DELISTED
Carisma Therapeutics
CARM
$61K ﹤0.01%
7,221
-1,271
-15% -$17.3K
INOD icon
2096
Innodata
INOD
$1.88B
$61K ﹤0.01%
20,228
+3,220
+19% +$14K
DSI icon
2097
iShares MSCI KLD 400 Social ETF
DSI
$5.17B
$60K ﹤0.01%
899
+355
+65% +$26.6K
EDC icon
2098
Direxion Daily MSCI Emerging Markets Bull 3X ETF
EDC
$140M
$60K ﹤0.01%
+2,576
New +$87.4K
SUSA icon
2099
iShares ESG Optimized MSCI USA ETF
SUSA
$4B
$60K ﹤0.01%
790
+247
+45% +$21K
WOOD icon
2100
iShares Global Timber & Forestry ETF
WOOD
$266M
$60K ﹤0.01%
+922
New +$69.4K

Similar funds

Qube Research & Technologies (QRT)'s Q3 2022 Portfolio in Review

As of Q3 2022, Qube Research & Technologies (QRT) held 3,295 positions worth $16.8B, up 24% from $13.6B the previous quarter. Its ten largest holdings account for 10% of the portfolio.

Qube Research & Technologies (QRT) deployed $4.87B of net new capital in Q3 2022, opening 862 new positions and adding to 762 existing holdings. Its largest new stake was Coca-Cola: 2,493,071 shares worth $140M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Marathon Petroleum, an estimated $174M trimmed.

  • Qube Research & Technologies (QRT)'s largest Q3 2022 buy was Coca-Cola: 2,493,071 shares worth $140M.
  • Qube Research & Technologies (QRT) added most to Visa in Q3 2022, an estimated $169M increase.
  • Qube Research & Technologies (QRT)'s biggest Q3 2022 reduction was Marathon Petroleum, cutting an estimated $174M.
  • Qube Research & Technologies (QRT) fully exited Phillips 66 in Q3 2022, selling an estimated $86.2M.
  • Qube Research & Technologies (QRT)'s ten largest holdings make up 10% of its $16.8B portfolio in Q3 2022.
  • Qube Research & Technologies (QRT) opened 862 new positions and closed 837 in Q3 2022.
  • Qube Research & Technologies (QRT)'s portfolio value rose 24% quarter-over-quarter to $16.8B.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2022, filed 14 Nov 2022.